Karachi: Tuberculosis (TB) is bad for health and destructive for pockets that make it impossible for patients to survive from the lethal disease because a massive price hike on TB medicines is on the cards in the local market.
The international prices of the raw materials of Rifampicin, which is used to produce one of the key drugs in the treatment of tuberculosis (TB), have increased by $22 per kilogram. The surge in raw material of prices will enhance thousands of rupees on the treatment of individual patients and will eat up million rupees in the budget of government-run hospitals.
Tuberculosis is a global emergency with a high prevalence of patients suffering from this disease in Pakistan. As Rifampicin is an essential component for tuberculosis therapy, it should be continued throughout the course of treatment just to avoid drug resistance.’
The rise in these prices will have an impact on the treatment options available, indicated in advance by Pharma Bureau – the representative organization of multinational pharmaceutical companies operating in Pakistan.
‘In order to maintain a continuous supply of tuberculosis treatment drugs, we need to be ensured that an appropriate price increase will be given to our member companies,’ said the Executive Director of Pharma Bureau Ayesha Tammy Haq.